
TJM Labs is pleased to announce that we are now an official Corporate Patron of the Alliance for Pharmacy Compounding (APC), the leading voice representing the pharmacy compounding profession.
Compounding plays a critical role in patient care, providing customized therapies when commercial drug products are unavailable, inappropriate, or ineffective. APC works to promote, protect, and advance the practice of pharmacy compounding through advocacy, education, and industry collaboration. Their work ensures compounders can continue to deliver the personalized treatments patients rely on.
Our decision to partner with APC reflects our long-standing commitment to supporting the compounding community and strengthening the ecosystem that supports it.
As part of the Corporate Patron Program, TJM Labs will engage with APC members and stakeholders to support best practices and continuous improvement. Together, we will help elevate awareness of the value of pharmacy compounding in patient care.
This partnership enables multiple members of the TJM Labs team to be actively involved across APC committees, working groups, and knowledge-sharing opportunities. Most importantly, it allows us to play a meaningful role in championing the future of compounding.
We look forward to collaborating with APC and compounding professionals across the country to promote safe, effective, and patient-centered pharmaceutical compounding.
If you are interested in learning more about APC and the Corporate Patron Program, visit: https://a4pc.org/patrons
